Literature DB >> 17017869

Apoptosis in Alzheimer disease: a mathematical improbability.

Xiongwei Zhu1, Arun K Raina, George Perry, Mark A Smith.   

Abstract

Neuronal cell dysfunction and death are cardinal features of Alzheimer disease and a great deal of effort is being expended not only to understand factors involved in the cause and progression of disease (i.e., disease initiators and propagators) but, ultimately, the precise mechanism by which neurons die (for want of a better word, the terminators). Understanding each and every component of the complex pathway that ultimately leads to disease (a clinical phenotype) is clearly of paramount importance for the development of effective therapeutic strategies. Of particular intrigue for many scientists, perhaps the more macabre among us, has been to decipher the final event - namely cell death. Broadly speaking, cell death falls into two categories, apoptotic and necrotic. The former, apoptosis, by definition, is a controlled event; thereby offering the potential for intervention, whereas necrosis is a more stochastic process. Since many of the propagators and exacerbators involved in Alzheimer disease are pro-apoptotic, it is not surprising that certain aspects of apoptosis are evident. However, it would be a mistake to call this apoptosis. In fact, as reviewed herein, the chronic course of disease together with the necessarily slow rate of neuronal death makes apoptotic cell death in Alzheimer disease a mathematical improbability. The numbers simply do not add up.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17017869     DOI: 10.2174/156720506778249470

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  31 in total

Review 1.  Autophagy in the brains of young patients with poorly controlled T1DM and fatal diabetic ketoacidosis.

Authors:  William H Hoffman; John J Shacka; Anuska V Andjelkovic
Journal:  Exp Mol Pathol       Date:  2011-11-06       Impact factor: 3.362

Review 2.  Pathological implications of cell cycle re-entry in Alzheimer disease.

Authors:  David J Bonda; Hyun-pil Lee; Wataru Kudo; Xiongwei Zhu; Mark A Smith; Hyoung-gon Lee
Journal:  Expert Rev Mol Med       Date:  2010-06-29       Impact factor: 5.600

3.  Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease.

Authors:  Siddhartha Mondragón-Rodríguez; Gustavo Basurto-Islas; Ismael Santa-Maria; Raúl Mena; Lester I Binder; Jesús Avila; Mark A Smith; George Perry; Francisco García-Sierra
Journal:  Int J Exp Pathol       Date:  2008-04       Impact factor: 1.925

Review 4.  A novel perspective on tau in Alzheimer's disease.

Authors:  D J Bonda; R J Castellani; X Zhu; A Nunomura; H-g Lee; G Perry; M A Smith
Journal:  Curr Alzheimer Res       Date:  2011-09       Impact factor: 3.498

5.  A perspective on neuronal cell death signaling and neurodegeneration.

Authors:  Scott Brady; Gerardo Morfini
Journal:  Mol Neurobiol       Date:  2010-05-18       Impact factor: 5.590

6.  Necroptosis activation in Alzheimer's disease.

Authors:  Antonella Caccamo; Caterina Branca; Ignazio S Piras; Eric Ferreira; Matthew J Huentelman; Winnie S Liang; Ben Readhead; Joel T Dudley; Elizabeth E Spangenberg; Kim N Green; Ramona Belfiore; Wendy Winslow; Salvatore Oddo
Journal:  Nat Neurosci       Date:  2017-07-24       Impact factor: 24.884

Review 7.  Oxidative stress signaling in Alzheimer's disease.

Authors:  B Su; X Wang; A Nunomura; P I Moreira; H-gon Lee; G Perry; M A Smith; X Zhu
Journal:  Curr Alzheimer Res       Date:  2008-12       Impact factor: 3.498

8.  Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664.

Authors:  Thuy-Vi V Nguyen; Veronica Galvan; Wei Huang; Surita Banwait; Huidong Tang; Junli Zhang; Dale E Bredesen
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

9.  C-myb Plays an Essential Role in the Protective Function of IGF-1 on Cytotoxicity Induced by Aβ25-35 via the PI3K/Akt Pathway.

Authors:  Jingyu Zhang; Yongwei Shu; Yang Qu; Lina Zhang; Tingting Chu; Yonghui Zheng; Hong Zhao
Journal:  J Mol Neurosci       Date:  2017-11-06       Impact factor: 3.444

Review 10.  Phosphorylated tau: toxic, protective, or none of the above.

Authors:  Rudy J Castellani; Akihiko Nunomura; Hyoung-gon Lee; George Perry; Mark A Smith
Journal:  J Alzheimers Dis       Date:  2008-08       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.